WO1993022291A1 - Arthropodicidal and fungicidal aminopyrimidines - Google Patents

Arthropodicidal and fungicidal aminopyrimidines Download PDF

Info

Publication number
WO1993022291A1
WO1993022291A1 PCT/US1993/002757 US9302757W WO9322291A1 WO 1993022291 A1 WO1993022291 A1 WO 1993022291A1 US 9302757 W US9302757 W US 9302757W WO 9322291 A1 WO9322291 A1 WO 9322291A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
haloalkyl
optionally substituted
halogen
alkoxyalkyl
Prior art date
Application number
PCT/US1993/002757
Other languages
French (fr)
Inventor
Renée Marie LETT
Original Assignee
E.I. Du Pont De Nemours And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E.I. Du Pont De Nemours And Company filed Critical E.I. Du Pont De Nemours And Company
Publication of WO1993022291A1 publication Critical patent/WO1993022291A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N55/00Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/30Germanium compounds

Definitions

  • This invention relates to aminopyrimidines
  • U.S. 4,895,849, U.S. 4,985,426, U.S. 4,435,402 and EP 424,125 each disclose aminopyrimidines useful as insecticides having substituents at the claimed R 3 position limited to H, halogen or lower alkyl.
  • DE 3,905,364 discloses certain aminopyrimidines as aldose reductase inhibitors.
  • This invention comprises compounds of Formula I, including all geometric and stereoisomers,
  • A is C 1 -C 5 straight or branched chain alkylene or C 3 -C 6 cycloalkylene, wherein any one atom of A can be optionally substituted with R 7 ;
  • X is Ge or Si;
  • R 1 is H, halogen, C 1 -C 4 -alkyl or C 1 -C 4 haloalkyl
  • R 2 is H, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 4 cyanoalkyl, C 2 -C 4 alkenyl, C 2 -C 4 haloalkenyl, C 2 -C 4 alkynyl, C 2 -C 6 alkoxyalkyl or C 2 -C 6 alkylthioalkyl;
  • R 3 is H, halogen, CN, NO 2 , CO 2 R 16 , C(O)R 16 ,
  • R 4 is H, formyl, C 2 -C 6 alkoxyalkyl C 2 -C 6 alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 2 -C 6
  • haloalkoxycarbonyl C(O)R 15 , R 11 OC(O)S-, R 11 OC(O)N(R 12 )S-, R 11 (R 12 )NS- or SR 8 ; or R 4 is C 1 -C 6 alkyl optionally substituted with halogen, CN, NO 2 , S(O) n R 11 , C(O)R 11 , CO 2 R 11 or C 1 -C 3 haloalkoxy; or R 4 is phenyl optionally substituted with halogen, CN, and C 1 -C 2 haloalkyl;
  • R 5 is C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 2 -C 6 alkoxyalkyl, C 2 -C 6 alkoxyalkoxy, C 2 -C 6 alkenyl, C 2 -C6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 alkenyloxy, C 2 -C 6 alkynyloxy, C 3 -C 6 cycloalkyl, C 3 -C 6 cycloalkylalkyl, C 1 -C 6 alkylthio, C 2 -C 6 alkylthioalkyl, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylthio, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 hal
  • R 6 is H, halogen, CN, NO 2 , C 1 -C 2 alkyl, C 1 -C 2 alkoxy or CF 3 ;
  • R 7 is CN, C(O)R 8 , CO 2 R 8 , C(O)N(R 8 )R 9 , N 3 , NO 2 ,
  • R 8 and R 10 are independently H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 3 -C 6 haloalkynyl, C 2 -C 6 alkoxyalkyl, C 2 -C 6 alkylthioalkyl, C 1 -C 6 nitroalkyl, C 2 -C 6 cyanoalkyl, C 3 -C 8 alkoxycarbonylalkyl, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, phenyl optionally substituted with W; or benzyl optionally substituted with W on the phenyl ring;
  • R 9 is H or C 1 -C 4 alkyl
  • R 8 and R 9 can be taken together when attached to the same atom as -(CH 2 ) 4 -, -(CH 2 ) 5 - or
  • R 11 and R 12 are independently C 1 -C 4 alkyl
  • R 13 is C 1 -C 4 alkyl, C 1 -C 4 alkoxyalkyl or phenyl
  • R 14 is C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, phenyl or benzyl, each phenyl or benzyl
  • R 15 is , , or ;
  • R 16 and R 17 are independently H, C 1 -C 4 alkyl or
  • W is CN, NO 2 , C 1 -C 2 alkyl, C 1 -C 2 haloalkyl, C 1 -C 2 alkoxy, C 1 -C 2 haloalkoxy, C 1 -C 2 alkylthio, C 1 -C 2 haloalkylthio, C 1 -C 2 alkylsulfonyl, C 1 -C 2 haloalkylsulfonyl or 1-5 halogens; and
  • n 0, 1 or 2.
  • Preferred Compounds A are compounds of Formula I
  • A is C 1 -C 5 straight or branched alkylene
  • R 1 is H
  • R 2 is C 1 -C 6 alkyl, C 2 -C 4 cyanoalkyl or C 1 -C 4 haloalkyl; R 4 is H;
  • R 5 is C 1 -C 6 alkyl, C 1 -C 6 haloalkoxy, C 2 -C 6 alkoxyalkyl, C 2 -C 6 alkoxyalkoxy or phenoxy optionally substituted with W;
  • R 6 is H, halogen or C 1 -C 2 alkyl;
  • R 11 , R 12 and R 13 are independently C 2 -C 2
  • R 14 is C 1 -C 4 alkyl, C 1 -C 4 alkoxy or phenyl
  • W is halogen or C 1 -C 2 haloalkyl.
  • Preferred Compounds B are compounds of Preferred A wherein Q is Q-1.
  • Preferred Compounds C are compounds of Preferred A wherein Q is Q-2.
  • Preferred Compounds D are compounds of Preferred A wherein Q is Q-3.
  • the present invention further comprises
  • compositions containing an effective amount of one or more compounds of Formula I and at least one of (a) a surfactant (b) an organic solvent, and (c) at least one solid or liquid diluent.
  • the present-invention further comprises a method for controlling foliar, aquatic and soil-inhabiting anthropod pests comprising application of an effective amount of a compound of Formula I or an agricultural composition as described above containing one or more compounds of Formula I to the locus of infestation, area to be protected, or directly onto said pests.
  • stereoisomers are meant all of the isomers of the Formula I compounds which include enantiomers, diastereomers, and geometric isomers.
  • enantiomers diastereomers
  • geometric isomers One skilled in the art will appreciate that one or the other of said stereoisomer (s) will be the more active. It is also known how to separate such enantiomers, diastereomers, and geometric isomers.
  • the present invention comprises racemic mixtures, individual stereoisomers, and optically active mixtures of compounds of Formula I as well as agriculturally suitable salts thereof.
  • alkyl used either alone or in a compound word such as “alkylthio” or “haloalkyl”, denotes straight or branched alkyl, e.g., methyl, ethyl, n-propyl, isopropyl, or the different butyl, pentyl or hexyl isomers.
  • Alkoxy denotes methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy or hexyloxy isomers.
  • Alkenyl denotes straight or branched chain alkenes such as vinyl, 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers.
  • Alkynyl denotes straight chain or branched alkynes such as ethynyl, 1-propynyl, 3-propynyl and the different butynyl, pentynyl and hexynyl isomers.
  • Alkylthio denotes methylthio, ethylthio and the different propylthio, butylthio, pentylthio and hexylthio isomers.
  • Alkylsulfinyl, alkylsulfonyl, alkylamino, etc. are defined analogously to the above examples.
  • Cycloalkyl denotes cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
  • halogen either alone or in compound words such as “haloalkyl”, denotes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as “haloalkyl” said alkyl may be partially or fully substituted with halogen atoms, which may be the same or different. Examples of haloalkyl include CH 2 CH 2 F, CF 2 CF 3 and CH 2 CHFCl.
  • halocycloalkyl “haloalkenyl” and “haloalkynyl” are defined analogously to the term “haloalkyl”.
  • C i -C j The total number of carbon atoms in a substituent group is indicated by the "C i -C j " prefix where i and j are numbers from 1 to 8.
  • C 1 -C 3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl
  • C 2 alkoxyalkoxy designates OCH 2 OCH 3
  • C 4 alkoxyalkoxy designates the various isomers of an alkoxy group substituted with a second alkoxy group containing a total of 4 carbon atoms, examples
  • cyanoalkyl designates CH 2 CN and C 3 cyanoalkyl
  • C 2 alkylcarbonyl would designates C(O)CH 3 and C 4 alkylcarbonyl includes C(O)CH 2 CH 2 CH 3 and C(O) CH (CH 3 ) 2 ; and as a final example, C 3 alkoxycarbonylalkyl designates CH 2 CO 2 CH 3 and C 4 alkoxycarbonylalkyl includes CH 2 CH 2 CO 2 CH 3 , CH 2 CO 2 CH 2 CH 3 and CH(CH 3 )CO 2 CH 3 .
  • insects include insects, mites and nematodes.
  • Z represents a displaceable group such as a halogen atom, an alkylthio group, or an alkyl- or arylsulfonyloxy group;
  • A, Q, R 2 and R 3 are as previously defined for Formula I .
  • the reaction of pyrimidine II with amine III is best carried out in the presence of an acid acceptor or base.
  • the base can be, but is not limited to, triethylamine, pyridine, sodium hydride, or potassium carbonate.
  • the synthetic process can be carried out in the absence or presence of a solvent. Suitable
  • solvents include those that will not participate in the above reaction, for example, toluene, xylene, ethanol, propanol, N,N-dimethylformamide, and N,N-dimethylacetamide.
  • Preferred temperatures for this process are from about 20°C to 200°C with temperatures between 80°C and 150°C being particularly preferred.
  • Compounds of Formula I where R 4 is an alkyl or acyl group can be best prepared by reacting an amine of Formula III where R 4 is an alkyl or acyl group with a pyrimidine of Formula II.
  • the amine of Formula III where R 4 is alkyl or acyl can be prepared by acylating or alkylating an amine of Formula III, where R 4 is equal to hydrogen, using conventional methods known to those skilled in the art.
  • Amines of Formula III wherein A is equal to CH 2 CH 2 can be prepared by reduction of nitriles of Formula IV using alane. In situ formation of alane in ether and then treatment with nitrile IV at 0°C gives the desired primary amines in high yields. Nitriles of Formula IV can in turn be synthesized by the displacement of a bromine atom from a bromide of Formula V with potassium cyanide as in Scheme 3, wherein Q is as previously defined for Formula I. SCHEME 3
  • Bromides of Formula V can be prepared according to the process shown in Scheme 4, wherein Q is as previously defined in Formula I, and NBS is N-bromosuccinimide.
  • Aryl methyl groups in compounds of Formula VI are subject to free radical bromination by N-bromosuccinimide (NBS) in the presence of light.
  • NBS N-bromosuccinimide
  • the dibromides can, in turn, be prepared from compounds of Formula VI.
  • Aryl methyl compounds of Formula VI are subject to free radical bromination with two equivalents of N-bromosuccinimide in the presence of light in refluxing carbon tetrachloride according to Scheme 7, wherein Q is as previously defined in
  • Pyrimidines of Formula II can be prepared by a variety of literature methods. Some efficient
  • Some pyrimidines of Formula II where R 3 is equal to halogen or nitro can be prepared by the reaction of a 4-pyrimidinol with an electrophile (Scheme 8). Electrophilic reagents that transfer halogen
  • pyrimidines of Formula II can be prepared by simple functional group transformations using
  • Palladium complexes of triarylphosphines are the preferred catalysts of this reaction.
  • Some examples are tetrakis (triphenylphosphine)pallpadium(O), bis (triphenylphosphine)palladium(II)dichloride, and tris- (dibenzylideneacetone)dipalladium(O) with 1,1'-bis
  • the reaction can be carried out in a variety of solvents including dimethylsulfoxide, dimethylformamide, triethylamine, tetrahydrofuran, dioxane, and toluene.
  • the temperature of the reaction is determined by the nature of the catalyst and displaceable group R 3 . Generally the reaction is carried out at temperatures in the range of 25°C to 200°C with temperatures of 60°C to 150°C being preferred.
  • reagents MR 3 are potassium cyanide, cuprous iodide with trimethylsilylacetylene, and vinyltrimethyltin. Detailed procedures are
  • R 3 is equal to CO 2 R 16 , C(O)R 16 , and CHO.
  • 6-ethyl-4-pyrimidinol (1.2 g, 10 mmole) and N-iodosuccinimide (2.2 g, 10 mmole) were heated at 61°C in chloroform (20 mL) for four hours.
  • the reaction mixture was cooled and concentrated under vacuum to a solid residue.
  • the crude solid was treated with hot water and filtered.
  • the moist solid was recrystallized from methanol to give a pure white solid product
  • Step B 4-chloro-6-ethyl-5-iodopyrimidine
  • Step C 6-ethyl-5-iodo-N-[1-[4-(trimethylsilyl)-phenyl]ethyl]-4-pyrimidinamine
  • Step B The product of Step B (1.5 g, 5.6 mmole), ⁇ -methyl-4-trimethylsilylbenzenemethanamine (1.1 g, 5.6 mmole), and triethylamine (1.6 mL, 11 mmole) were dissolved in toluene (5 mL) and heated at 110°C for 24 hours. The reaction mixture was cooled and treated with water and ether. After extraction of the aqueous phase with ether, the combined organic phases were dried (MgSO 4 ), concentrated, and chromatographed on silica gel with 10% ethyl acetate/ hexane. The resultant product was a waxy solid (1.9 g, 82% yield).
  • Step D 6-ethyl-4-[[1-[4-(trimethylsilyl)phenyl]-ethyl]amino]-5-pyrimidinecarbonitrile
  • Step D ⁇ -methyl-4-trimethylsilylbenzenemethanamine The product of Step C (91 g, 0.28 mole) and
  • Step E 6-ethyl-N-[1-[4-(trimethylsilyl)phenyl]ethyl]-4-pyrimidinamine
  • 6-ethyl-4-pyrimidinol (1.0 g, 8.5 mmole) was dissolved in 10 mL of tetramethylene sulfone by warming to 30°C. Nitronium tetrafluoroborate (2.5 g, 19 mmole) was added portionwise and the reaction mixture was heated at 60°C for one hour. The reaction was cooled, poured into ice water, and extracted several times with ethyl acetate. The combined organic phases were washed two times with water, dried (MgSO 4 ), concentrated, and chromatographed on silica gel with 10% methanol/ chloroform. The product was an orange solid (0.85 g, 59% yield).
  • Step B 4-chloro-6-ethyl-5-nitropyrimidine
  • Step A The product of Step A (0.85 g, 5.0 mmole) was combined with phosphorus oxychloride (10 mL) and heated at 100°C for one hour, during which the slurry became homogeneous. The mixture was concentrated under vacuum and the residue was added to ice. Concentrated NH 4 OH solution was carefully added until the aqueous phase was basic. This solution was extracted several times with ether and the combined organic phases were dried (MgSO 4 ) and concentrated to give a waxy solid product (0.64 g, 68% yield).
  • Step C 6-ethyl-5-nitro-N-[1-[4-(trimethylsilyl)-phenyl]-ethyl]-4-pyrimidinamine
  • Tables 1 to 4 can be prepared.
  • the compounds in Table 1, line 1 can be referred to as 1-1, 1-2, 1-3, 1-4 and 1-5 (as designated by line and column). All the other specific compounds covered in these Tables can be designated in an analogous fashion relying on the Table number to help distinguish between compounds 1-1 of Table 1 and 1-1 of Table 2, etc.
  • Compounds of this invention will generally be used in formulation with an agriculturally suitable carrier comprising a liquid or solid diluent or an organic solvent.
  • Useful formulations can be prepared in conventional ways. They include dusts, granules, baits, pellets, solutions, suspensions, emulsions, wettable powders, emulsifiable concentrates, dry flowables and the like. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High strength compositions are primarily used as intermediates for further formulation.
  • formulations will typically contain effective amounts of an active ingredient, diluent and a surfactant within the following approximate ranges wherein the active ingredient plus surfactant and/or diluent equals 100 weight percent.
  • compositions Typical solid diluents are described in Watkins, et al., Handbook of Insecticide Dust Diluents and
  • All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth, etc.
  • ingredients should be approved by the U.S. Environmental Protection Agency for the use intended.
  • Solutions are prepared by simply mixing the ingredients. Fine solid compositions are made by blending and, usually, grinding as in a hammer mill or fluid energy mill. Water-dispersible granules can be produced be agglomerating a fine powder composition; see for example, Cross et al., Pesticide Formulations, Washington, D.C., 1988, pp. 251-259. Suspensions are prepared by wet-milling; see, for example, U.S.
  • Granules and pellets can be made by
  • Pellets can be prepared as described in U.S. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in DE 3,246,493.
  • the ingredients are blended and ground in a hammer mill to produce a high strength concentrate
  • Compound 1 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium ligninsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0%
  • the ingredients are thoroughly blended.
  • the liquid surfactant is added by spraying upon the solid
  • Compound 1 10.0% attapulgite granules (low volative matter, 0.71/0.30 mm; U.S.S. No.
  • the active ingredient is dissolved in a volatile solvent such as acetone and sprayed upon dedusted and pre-warmed attapulgite granules in a double cone blender.
  • a volatile solvent such as acetone
  • the acetone is then driven off by heating , and the granules are allowed to cool.
  • Compound 1 25.0% hydrated attapulgite 3.0% crude calcium ligninsulfonate 10.0% sodium dihydrogen phosphate 0.5% water 61.5% The ingredients are ground together in a ball mill or roller mill until the solid particles have been reduced to diameters under 10 microns.
  • Compound 1 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate 5.0% sodium alkylnaphthalenesulfonate 1.0% calcium/magnesium bentonite 59.0%
  • the ingredients are blended, hammer-milled and then moistened with about 12% water. The mixture is extruded as cylinders about 3 mm diameter which are cut to produce pellets about 3 mm long. These can be used directly after drying, or the dried pellets can be crushed to pass a U.S.S. No. 20 sieve (0.84 mm
  • the granules held on a U.S.S. No. 40 sieve (0.42 mm openings) can be used and the fines recycled.
  • Compound 1 20.0% blend of oil soluble sulfonates and polyoxyethylene ethers 10.0% isophorone 70.0%
  • the ingredients are combined and stirred with gentle warming to speed solution.
  • a fine screen filter is included in packaging operation to insure the absence of extraneous undissolved material in the product.
  • Wettable powder of Example B 10.0% pyrophyllite (powder) 90.0%
  • the wettable powder and the pyrophyllite diluent are thoroughly blended.
  • the compounds of this invention exhibit activity against a wide spectrum of foliar-feeding, fruit-feeding, seed-feeding, aquatic and soil-inhabiting arthropods (term includes insects, mites and nematodes) which are pests of growing and stored agronomic crops, forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health.
  • arthropods term includes insects, mites and nematodes
  • Those skilled in the art will appreciate that not all compounds are equally effective against all pests. Nevertheless, all of the compounds of this invention display activity against pests that include: eggs, larvae and adults of the
  • Order Lepidoptera eggs, foliar-feeding, fruit-feeding, root-feeding, seed-feeding larvae and adults of the Order Coleoptera; eggs, immatures and adults of the Orders Hemiptera and Homoptera; eggs, larvae, nymphs and adults of the Order Acari; eggs, immatures and adults of the Orders Thysanoptera, Orthoptera and
  • the compounds of this invention are also active against pests of the Orders Hymenoptera,
  • the compounds of this invention are also useful as plant disease control agents. They provide control of diseases caused by a broad spectrum of fungal plant pathogens in the Basidiomycete, Ascomycete and Oomycete classes. They are effective in controlling a broad spectrum of plant diseases, particularly foliar
  • pathogens of ornamental, vegetable, field, cereal, and fruit crops include Plasmopara viticola, Phytophthora infestans, Peronospora tabacina, Pseudoperonospora cubensis, Pythium aphanidermatum, Alternaria brassicae, Septoria nodorum, Cercosporidium personatum, Cercospora arachidicola, Pseudocercosporella herpotrichoides, Rhizoctinia Solani, Cercospora beticola, Botrytis cinerea, Monilinia fructicola, Pyricularia oryzae, Podosphaera
  • the compounds of this invention also control seed pathogens.
  • Compounds of this invention can also be mixed with one or more other insecticides, fungicides,
  • insecticides such as monocrotophos, carbofuran, avermectin B, tetrachlor-vinphos, malathion, parathion-methyl, methomyl, chlor- dimeform, diazinon, deltamethrin, oxamyl, fenvalerate, esfenvalerate, permethrin, profenofos, sulprofos, triflumuron, diflubenzuron, methoprene, buprofezin, thiodicarb, acephate, azinphosmethyl, chlorpyrifos, dimethoate, fonophos, isofenphos, methidathion, metha-midophos, phosmet, phosphamidon, phosalone, pirimicarb, phorate, terbufos, trichlorfon, methoxychlor,
  • fungicides such as carbendazim, thiuram, dodine, maneb, chloroneb, benomyl, cymoxanil,
  • bactericides such as oxytetracyline, streptomycin and tribasic copper sulfate; acaricides such as binapacryl, oxythioquinox, chlorobenzilate, dicofol, dienochlor, cyhexatin, hexythiazox, amitraz, propargite and fenbutatin oxide; and biological agents such as Bacillus thuringiensis, and baculovirus.
  • Arthropod pests are controlled and protection of agronomic crops, animal and human health is achieved by applying one or more of the compounds of this
  • a preferred method of application is by spraying with equipment that distributes the compound in the
  • granular formulations of these compounds can be applied to the foliage or applied to or
  • the compounds can be incorporated into baits that are consumed by the arthropods or in devices such as traps and the like which entice them to ingest or otherwise contact the compounds.
  • Plant disease control is ordinarily accomplished by applying an effective amount of a compound of this invention either pre- or post-infection, to the portion of the plant to be protected such as the roots, stems, foliage, fruit, seeds, tubers or bulbs, or to the media (soil or sand) in which the plants to be protected are growing.
  • the compounds can also be applied to the seed to protect the seed and seedling.
  • the compounds of this invention can be applied in their pure state, but most often application will be of a formulation comprising one or more compounds with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use.
  • suitable carriers diluents, and surfactants
  • the rate of application required for effective control arthropod will depend on such factors as the species of arthropod to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like. In general, application rates of about 0.01 to 2 kg of active ingredient per hectare are sufficient to provide large-scale effective control of pests in agronomic ecosystems under normal circumstances, but as little as 0.001 kg/hectare may be sufficient or as much as 8 kg hectare may be required. For nonagronomic
  • 0.1 mg/square meter may be sufficient or as much as 150 mg/square meter may be required.
  • Rates of application for these compounds as plant disease control agents can be influenced by many factors of the environment and should be determined under actual use conditions. Foliage can normally be protected when treated at a rate of from less than 1 g/ha to 10,000 g/ha of active ingredient. Seed and seedlings can normally be protected when seed is treated at a rate of from 0.1 to 10 g per kilogram of seed.
  • test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem ® 014 (polyhydric alcohol esters). This suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore dust of Erysiphe graminis f. sp . tritici (the causal agent of wheat powdery mildew) and incubated growth chamber at 20°C for 7 days, after which disease ratings were made. Of the compounds tested, the following gave 70% disease control or higher: 1, 2, 3, 4, 5, 7, 8, 9, 10, 12, 13, 14, 15, 16, 17, 18.
  • test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then
  • test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then
  • test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem ® 014 (polyhydric alcohol esters). This suspension is sprayed to the point of run-off on rice seedlings. The following day the seedlings are inoculated with a spore suspension of Pyricularia oryzae (the causal agent of rice blast) and incubated in a saturated atmosphere at 27°C for 24 h, and then moved to a growth chamber at 30°C for 5 days, after which disease ratings are made. Of. the compounds tested, the following gave 70% disease control or higher: 1, 2, 7, 18.
  • kidney bean leaves that have been infested on the undersides with 25 to 30 adult mites ( Tetranychus urticae) were sprayed with their undersides facing up on a hydraulic sprayer.
  • the leaf-squares were placed underside up on a square of wet cotton in a petri dish and the perimeter of the leaf square was tamped down onto the cotton with forceps so that the mites cannot escape onto untreated leaf surface.
  • the test units were held at 27°C and 50% relative humidity for 48 hrs., after which time

Abstract

Aminopyrimidines characterized by various substitution at the 5-position of the pyrimidine ring and agricultural compositions containing them useful for the control of anthropods in both agronomic and nonagronomic environments are disclosed.

Description

TITLE
ARTHROPODICIDAL AND FUNGICIDAL AMINOPYRIMIDINES
This invention relates to aminopyrimidines
characterized by various substitution at the 5-position of the pyrimidine ring useful as arthropodicides and fungicides, their agriculturally suitable compositions, and methods of their use against foliar, aquatic, and soil-inhabiting anthropods and plant pathogens.
U.S. 4,895,849, U.S. 4,985,426, U.S. 4,435,402 and EP 424,125 each disclose aminopyrimidines useful as insecticides having substituents at the claimed R3 position limited to H, halogen or lower alkyl. DE 3,905,364 discloses certain aminopyrimidines as aldose reductase inhibitors.
SUMMARY OF THE INVENTION
This invention comprises compounds of Formula I, including all geometric and stereoisomers,
agriculturally suitable salts thereof, agricultural compositions containing them and their use as
arthropodicides and fungicides in both agronomic and nonagronomic environments. The compounds are
Figure imgf000003_0001
wherein
Q is
,
or
Figure imgf000004_0001
Figure imgf000004_0003
;
Figure imgf000004_0002
A is C1-C5 straight or branched chain alkylene or C3-C6 cycloalkylene, wherein any one atom of A can be optionally substituted with R7; X is Ge or Si;
R1 is H, halogen, C1-C4 -alkyl or C1-C4 haloalkyl; R2 is H, halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C4 cyanoalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl;
R3 is H, halogen, CN, NO2, CO2R16, C(O)R16,
C(O)N(R16)R17, OR16, SR16, S(O)R16, S(O)2R16, N(R16)R17, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C1-C6 hydroxyalkyl, C2-C6 alkoxyalkyl, C2-C6 haloalkoxyalkyl, C2-C6 cyanoalkyl, C1-C6 alkylthioalkyl, C2-C6 haloalkylthioalkyl, C3-C4 cycloalkyl, SCN or C1-C6 alkyl substituted with N(R16)R17; provided that (i) when R2 is H, halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl then R3 is other than halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl and (ii) when R3 is H, then R5 is other than C1-C6 haloalkylthio, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, C1-C6 alkylsulfonyl, C1-C6
alkylsulfinyl or C1-C6 alkylthio;
R4 is H, formyl, C2-C6 alkoxyalkyl C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6
haloalkoxycarbonyl, C(O)R15, R11OC(O)S-, R11OC(O)N(R12)S-, R11(R12)NS- or SR8; or R4 is C1-C6 alkyl optionally substituted with halogen, CN, NO2, S(O)nR11, C(O)R11, CO2R11 or C1-C3 haloalkoxy; or R4 is phenyl optionally substituted with halogen, CN, and C1-C2 haloalkyl;
R5 is C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkoxyalkyl, C2-C6 alkoxyalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 alkenyloxy, C2-C6 alkynyloxy, C3-C6 cycloalkyl, C3-C6 cycloalkylalkyl, C1-C6 alkylthio, C2-C6 alkylthioalkyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylthio, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, phenyl optionally substituted with W or phenoxy optionally substituted with W;
R6 is H, halogen, CN, NO2, C1-C2 alkyl, C1-C2 alkoxy or CF3;
R7 is CN, C(O)R8, CO2R8, C(O)N(R8)R9, N3, NO2,
N(R8)R9, N(R8)C(O)R9, N (R8) C (O) N (R10) R9, N(R8)S(O)2R10, OR8, OC(O)R8, OCO2R8,
OC(O)N(R8)R9, OS(O)2R8, SR8, S(O)R8, S(O)2R8, SCN or 1-3 halogens;
R8 and R10 are independently H, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C3-C6 haloalkynyl, C2-C6 alkoxyalkyl, C2-C6 alkylthioalkyl, C1-C6 nitroalkyl, C2-C6 cyanoalkyl, C3-C8 alkoxycarbonylalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, phenyl optionally substituted with W; or benzyl optionally substituted with W on the phenyl ring;
R9 is H or C1-C4 alkyl; or
R8 and R9 can be taken together when attached to the same atom as -(CH2)4-, -(CH2)5- or
-CH2CH2OCH2CH2-;
R11 and R12 are independently C1-C4 alkyl;
R13 is C1-C4 alkyl, C1-C4 alkoxyalkyl or phenyl
optionally substituted with W;
R14 is C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, phenyl or benzyl, each phenyl or benzyl
optionally substituted with W on the aryl ring;
R15 is
Figure imgf000006_0001
,
Figure imgf000006_0002
, or ;
Figure imgf000006_0003
Figure imgf000006_0004
R16 and R17 are independently H, C1-C4 alkyl or
C1-C4 haloalkyl;
W is CN, NO2, C1-C2 alkyl, C1-C2 haloalkyl, C1-C2 alkoxy, C1-C2 haloalkoxy, C1-C2 alkylthio, C1-C2 haloalkylthio, C1-C2 alkylsulfonyl, C1-C2 haloalkylsulfonyl or 1-5 halogens; and
n is 0, 1 or 2.
Preferred Compounds A are compounds of Formula I
wherein:
A is C1-C5 straight or branched alkylene;
R1 is H;
R2 is C1-C6 alkyl, C2-C4 cyanoalkyl or C1-C4 haloalkyl; R4 is H;
R5 is C1-C6 alkyl, C1-C6 haloalkoxy, C2-C6 alkoxyalkyl, C2-C6 alkoxyalkoxy or phenoxy optionally substituted with W; R6 is H, halogen or C1-C2 alkyl;
R11, R12 and R13 are independently C2-C2
alkyl;
R14 is C1-C4 alkyl, C1-C4 alkoxy or phenyl
optionally substituted with W; and
W is halogen or C1-C2 haloalkyl.
Preferred Compounds B are compounds of Preferred A wherein Q is Q-1. Preferred Compounds C are compounds of Preferred A wherein Q is Q-2. Preferred Compounds D are compounds of Preferred A wherein Q is Q-3.
Specifically preferred for biological activity is the compound of Preferred D which is:
6-ethyl-4-[[1-[4-(trimethylsilyl)phenyl]ethyl]- amino]-5-pyrimidinecarbonitrile.
The present invention further comprises
agricultural compositions containing an effective amount of one or more compounds of Formula I and at least one of (a) a surfactant (b) an organic solvent, and (c) at least one solid or liquid diluent.
The present-invention further comprises a method for controlling foliar, aquatic and soil-inhabiting anthropod pests comprising application of an effective amount of a compound of Formula I or an agricultural composition as described above containing one or more compounds of Formula I to the locus of infestation, area to be protected, or directly onto said pests.
DETAILED DESCRIPTION OF THE INVENTION
Compounds of the instant invention include racemic and optically active stereoisomers. By "stereoisomers" is meant all of the isomers of the Formula I compounds which include enantiomers, diastereomers, and geometric isomers. One skilled in the art will appreciate that one or the other of said stereoisomer (s) will be the more active. It is also known how to separate such enantiomers, diastereomers, and geometric isomers.
Accordingly, the present invention comprises racemic mixtures, individual stereoisomers, and optically active mixtures of compounds of Formula I as well as agriculturally suitable salts thereof.
In the above recitations, the term "alkyl" used either alone or in a compound word such as "alkylthio" or "haloalkyl", denotes straight or branched alkyl, e.g., methyl, ethyl, n-propyl, isopropyl, or the different butyl, pentyl or hexyl isomers. Alkoxy denotes methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy or hexyloxy isomers.
Alkenyl denotes straight or branched chain alkenes such as vinyl, 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers. Alkynyl denotes straight chain or branched alkynes such as ethynyl, 1-propynyl, 3-propynyl and the different butynyl, pentynyl and hexynyl isomers. Alkylthio denotes methylthio, ethylthio and the different propylthio, butylthio, pentylthio and hexylthio isomers. Alkylsulfinyl, alkylsulfonyl, alkylamino, etc., are defined analogously to the above examples. Cycloalkyl denotes cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
The term "halogen", either alone or in compound words such as "haloalkyl", denotes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as "haloalkyl" said alkyl may be partially or fully substituted with halogen atoms, which may be the same or different. Examples of haloalkyl include CH2CH2F, CF2CF3 and CH2CHFCl. The terms "halocycloalkyl", "haloalkenyl" and "haloalkynyl" are defined analogously to the term "haloalkyl".
The total number of carbon atoms in a substituent group is indicated by the "Ci-Cj" prefix where i and j are numbers from 1 to 8. For example, C1-C3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl; C2 alkoxyalkoxy designates OCH2OCH3; C4 alkoxyalkoxy designates the various isomers of an alkoxy group substituted with a second alkoxy group containing a total of 4 carbon atoms, examples
including OCH2OCH2CH2CH3 and OCH2CH2OCH2CH3; C2
cyanoalkyl designates CH2CN and C3 cyanoalkyl
designates CH2CH2CN and CH(CN)CH3; C2 alkylcarbonyl would designates C(O)CH3 and C4 alkylcarbonyl includes C(O)CH2CH2CH3 and C(O) CH (CH3)2; and as a final example, C3 alkoxycarbonylalkyl designates CH2CO2CH3 and C4 alkoxycarbonylalkyl includes CH2CH2CO2CH3, CH2CO2CH2CH3 and CH(CH3)CO2CH3.
For the sake of convenience, the term "arthropod" as used herein includes insects, mites and nematodes.
Compounds of Formula I can be prepared according to the reaction shown in Scheme 1. In this scheme, Z represents a displaceable group such as a halogen atom, an alkylthio group, or an alkyl- or arylsulfonyloxy group; A, Q, R2 and R3 are as previously defined for Formula I .
SCHEME 1
Figure imgf000009_0001
The reaction of pyrimidine II with amine III is best carried out in the presence of an acid acceptor or base. The base can be, but is not limited to, triethylamine, pyridine, sodium hydride, or potassium carbonate. The synthetic process can be carried out in the absence or presence of a solvent. Suitable
solvents include those that will not participate in the above reaction, for example, toluene, xylene, ethanol, propanol, N,N-dimethylformamide, and N,N-dimethylacetamide. Preferred temperatures for this process are from about 20°C to 200°C with temperatures between 80°C and 150°C being particularly preferred.
Compounds of Formula I where R4 is an alkyl or acyl group can be best prepared by reacting an amine of Formula III where R4 is an alkyl or acyl group with a pyrimidine of Formula II. The amine of Formula III where R4 is alkyl or acyl can be prepared by acylating or alkylating an amine of Formula III, where R4 is equal to hydrogen, using conventional methods known to those skilled in the art.
A particularly useful method for preparing some of the amines of Formula III is shown in Scheme 2, wherein Q is as previously defined for Formula I.
SCHEME 2
Figure imgf000010_0001
Amines of Formula III wherein A is equal to CH2CH2 can be prepared by reduction of nitriles of Formula IV using alane. In situ formation of alane in ether and then treatment with nitrile IV at 0°C gives the desired primary amines in high yields. Nitriles of Formula IV can in turn be synthesized by the displacement of a bromine atom from a bromide of Formula V with potassium cyanide as in Scheme 3, wherein Q is as previously defined for Formula I. SCHEME 3
Figure imgf000011_0001
This reaction can be accomplished in refluxing ethanol and water as co-solvents. Bromides of Formula V can be prepared according to the process shown in Scheme 4, wherein Q is as previously defined in Formula I, and NBS is N-bromosuccinimide.
SCHEME 4
Figure imgf000011_0002
Aryl methyl groups in compounds of Formula VI are subject to free radical bromination by N-bromosuccinimide (NBS) in the presence of light. The reaction is commonly done in refluxing carbon
tetrachloride with one equivalent of NBS. Compounds of Formula VI are either commercially available or can be prepared by conventional methods. Silylated compounds of Formula VI can be prepared according to the methods described by Habich et al. in Syn . , 1979, 841. The germylated compounds related to Formula VI can be made by simple modification of the procedure used for the silylated compounds that will be obvious to one skilled in the art.
Another particularly useful method for the
preparation of some of the amines of Formula III is shown in Scheme 5, wherein Q is as previously defined for Formula I, and TMS is trimethylsilyl. SCHEME 5
Figure imgf000012_0001
This process utilizes the method of Hart et al. described in J. Org. Chem . , 1983, 48, 289. Amines of Formula III where A is equal to CHCH2CH3 are prepared from aldehydes of Formula VII by treatment with lithium hexamethyldisilazide in tetrahydrofuran at 0°C followed by addition of ethyl Grignard and refluxing. Some aldehydes of Formula VII can be prepared by reaction of dibromides of Formula VIII with silver nitrate in refluxing water/dimethoxyethane solvent according to Scheme 6, wherein Q is as previously defined in
Formula I.
SCHEME 6
Figure imgf000012_0002
The dibromides can, in turn, be prepared from compounds of Formula VI. Aryl methyl compounds of Formula VI are subject to free radical bromination with two equivalents of N-bromosuccinimide in the presence of light in refluxing carbon tetrachloride according to Scheme 7, wherein Q is as previously defined in
Formula I. SCHEME 7
Figure imgf000013_0001
The amines of Formula III prepared in Schemes 2 and 5 can be used in Scheme 1 to prepare preferred
compounds of Formula I of this invention.
Pyrimidines of Formula II can be prepared by a variety of literature methods. Some efficient
processes are described by Foster et al. in Org. Syn . , 1955, 35, 80, Ube Industries in JP 58(83) 222,070, and Lonza Ag in EP 370,391. Some pyrimidines of Formula II where R3 is equal to halogen or nitro can be prepared by the reaction of a 4-pyrimidinol with an electrophile (Scheme 8). Electrophilic reagents that transfer halogen
SCHEME 8
Figure imgf000013_0002
(chlorine and N-iodosuccinimide) and nitro (nitronium tetrafluoroborate) are known. Processes similar to the above are described by Ciba Geigy in EP 470,600.
Some pyrimidines of Formula II can be prepared by simple functional group transformations using
conventional methods known to those skilled in the art. For example, reduction of a pyrimidine of Formula II where R3 is equal to NO2 to a pyrimidine of Formula II where R3 is equal to NH2 with hydrogen and Raney nickel in ethanol. Another example is displacement of bromide from a compound of Formula I where R3 is equal to Br with sodium methylthiolate (NaSCH3) to give a compound of Formula I where R3 is equal to SCH3. This material may be further oxidized with metachloroperbenzoic acid to give a compound of Formula I where R3 is equal to S(O)CH3 or S(O)2CH3.
Some of the preferred compounds of Formula I may be prepared by Palladium catalyzed reactions as shown in Scheme 9, wherein A, Q and R2 are as originally defined in Formula I.
SCHEME 9
Figure imgf000014_0001
Palladium complexes of triarylphosphines are the preferred catalysts of this reaction. Some examples are tetrakis (triphenylphosphine)pallpadium(O), bis (triphenylphosphine)palladium(II)dichloride, and tris- (dibenzylideneacetone)dipalladium(O) with 1,1'-bis
(diphenylphosphino) ferroccene ligand. The reaction can be carried out in a variety of solvents including dimethylsulfoxide, dimethylformamide, triethylamine, tetrahydrofuran, dioxane, and toluene. The temperature of the reaction is determined by the nature of the catalyst and displaceable group R3. Generally the reaction is carried out at temperatures in the range of 25°C to 200°C with temperatures of 60°C to 150°C being preferred. Examples of reagents MR3 are potassium cyanide, cuprous iodide with trimethylsilylacetylene, and vinyltrimethyltin. Detailed procedures are
described by Takagi et al. in Bull . Chem . Soc. Jpn . , 1991, 64, 1118, Sakamoto et al. in Synthesis, 1983, 312, and in "Palladium Reagents in Organic Synthesis" by R. F. Heck (Academic Press, 1985).
Palladium catalyzed carbonylation according to the procedures of Dolle and Kruse (Chem . Comm . , 1987, 904) and Baillargeon and Stille ( J. Amer. Chem . Soc , 1986, 108, 452) may be employed to prepare compounds of
Formula I where R3 is equal to CO2R16, C(O)R16, and CHO.
EXAMPLE 1
Step A: 6-ethyl-5-iodo-4-pyrimidinol
6-ethyl-4-pyrimidinol (1.2 g, 10 mmole) and N-iodosuccinimide (2.2 g, 10 mmole) were heated at 61°C in chloroform (20 mL) for four hours. The reaction mixture was cooled and concentrated under vacuum to a solid residue. The crude solid was treated with hot water and filtered. The moist solid was recrystallized from methanol to give a pure white solid product
(1.5 g, 60% yield), mp 192-3°C. 1H NMR (CDCl3): δ 13.12 (brs, 1H), 8.10 (s, 1H), 2.90 (q, 2H), 1.26 (t, 3H).
Step B: 4-chloro-6-ethyl-5-iodopyrimidine
The product of Step A (1.5 g, 6 mmole) was
suspended in phosphorus oxychloride (10 mL) and heated at 100°C for 20 minutes during which the solid
dissolved. The dark solution was cooled and
concentrated under vacuum. The resultant oil was poured onto ice and carefully neutralized with
concentrated NH4OH solution. After extracting the aqueous solution several times with methylene chloride, the combined organic phases were dried (MgSO4) and concentrated. The resultant product was a waxy yellow solid (1.6 g, 93% yield). 1H NMR (CDCl3): δ 8.74 (s, 1H), 3.04 (q, 2H), 1.31 (t, 3H).
Step C: 6-ethyl-5-iodo-N-[1-[4-(trimethylsilyl)-phenyl]ethyl]-4-pyrimidinamine
The product of Step B (1.5 g, 5.6 mmole), α-methyl-4-trimethylsilylbenzenemethanamine (1.1 g, 5.6 mmole), and triethylamine (1.6 mL, 11 mmole) were dissolved in toluene (5 mL) and heated at 110°C for 24 hours. The reaction mixture was cooled and treated with water and ether. After extraction of the aqueous phase with ether, the combined organic phases were dried (MgSO4), concentrated, and chromatographed on silica gel with 10% ethyl acetate/ hexane. The resultant product was a waxy solid (1.9 g, 82% yield). 1H NMR (CDCl3): δ 8.32 (s, 1H), 7.50, 7.35 (ABq, 4H), 5.75 (brd, 1H), 5.35 (m, 1H), 2.88 (q, 2H), 1.59 (d, 3H), 1.24 (t, 3H), 0.26 (s, 9H).
Step D: 6-ethyl-4-[[1-[4-(trimethylsilyl)phenyl]-ethyl]amino]-5-pyrimidinecarbonitrile
Tetrakis(triphenylphosphine)palladium (0.81 g, 0.7 mmole) and the iodide from Step C (3.0 g,
7.0 mmole) were dissolved in tetrahydrofuran (7 mL). Potassium cyanide (0.68 g, 10 mmole) was added and the slurry was heated at 65°C for 36 hours. Additional palladium catalyst (0.1 g) and potassium cyanide
(0.1 g) was added and the heating continued for another eight hours. After cooling the solution was diluted with water and ether and partitioned. The aqueous phase was extracted three times with ether and the combined organic phases were washed once with water, dried (MgSO4), and concentrated. The crude residue was chromatographed on silica gel with 10% ethyl
acetate/hexane. The resulting product was a white solid (1.75 g, 77% yield), mp 98-100°C. 1H NMR
(CDCl3): δ 8.59 (s, 1H), 7.52, 7.34 (ABq, 4H), 5.64 (brd, 1H), 5.43 (m, 1H), 2.82 (q, 2H), 1.61 (d, 3H), 1.30 (t, 3H), 0.26 (s, 9H). IR (nujol, cm-1): 2226 (m).
EXAMPLE 2
Step A: 1-ethyl-4-trimethylsilylbenzene
Magnesium (9.5 g, 0.39 mole) was suspended in tetrahydrofuran (THF) (60 mL) at room temperature. A solution of 4-bromo-l-ethylbenzene (49 mL, 0.36 mole) in 300 mL of THF was added dropwise at such a rate as to maintain the temperature between 30 and 60°C. When the addition was complete the reaction mixture was stirred for an additional hour and then cooled to 30°C. Trimethylsilyl chloride (49 mL, 0.39 mole) was added dropwise at such a rate as to maintain the temperature between 30 and 40°C. The thin suspension was stirred overnight at room temperature. Saturated aqueous NH4Cl was added and the reaction mixture partitioned. The aqueous phase was extracted three times with ether, and the combined organic phases were dried (MgSO4) and concentrated. The resultant oil (60 g, 93% yield) was used in the next step without further purification. 1H NMR (CDCl3): δ 7.43, 7.22 (ABq, 4H), 2.64 (q, 2H), 1.24 (t, 3H), 0.25 (s, 9H).
Step B: 1-bromo-1-[4-trimethylsilylphenyl]ethane
The product of Step A (59 g, 0.33 mole) was
dissolved in carbon tetrachloride (700 mL). To this solution was added N-bromosuccinimide (59 g, 0.33 mole) and benzoyl peroxide (ca. 200 mg) in one portion. The reation mixture was heated to reflux for 2.5 hours while being irradiated with a 275 watt sunlamp. After cooling, the solid succinimide was removed by
filtration and the filtrate was washed with saturated aqueous NaHSO3. Drying (MgSO4) and concentration gave an oil (77 g, 91% yield) which was used in the next step without further purification. 1H NMR (CDCl3): δ 7.48, 7.43 (ABq, 4H), 5.20 (q, 1H), 2.07 (d, 3H), 0.26 (s, 9H). Step C: 1 [4-trimethylsilylphenyl]-1-N-phthalimido-ethane
The product from Step B (77 g, 0.30 mole) and potassium phthalimide (58 g, 0.31 mole) were dissolved in dimethylformamide (DMF) (300 mL). The reaction mixture was heated to 80°C for one hour and then concentrated under vacuum at 80°C to remove most of the DMF. The residue was taken up in water and extracted three times with ether, dried (MgSO4) and concentrated to give an oil (91 g, 94% yield) which was used in the next step without further purification. 1H NMR
(CDCl3): δ 7.80 (m, 2H), 7.69 (m, 2H), 7.49 (s, 4H), 5.57 (q, 1H), 1.93 (d, 3H), 0.23 (s, 9H).
Step D: α-methyl-4-trimethylsilylbenzenemethanamine The product of Step C (91 g, 0.28 mole) and
hydrazine monohydrate (14 mL, 0.29 mole) were dissolved in methanol (400 mL) and heated to reflux for two hours. After cooling, the reaction mixture was poured into 6% aqueous K2CO3 solution. The aqueous mixture was extracted three times with ether and the combined organic phases were dried (MgSO4) and concentrated to give an oil (49 g, 90% yield) which was used in the next step without further purification. 1H NMR
(CDCl3): δ 7.48, 7.35 (ABq, 4H), 4.10 (q, 1H), 1.65 (brs, 2H), 1.39 (d, 3H), 0.26 (s, 9H).
Step E: 6-ethyl-N-[1-[4-(trimethylsilyl)phenyl]ethyl]-4-pyrimidinamine
The product of Step D (1.13 g, 5.8 mmole),
4-chloro-6-ethylpyrimidine (0.83 g, 5.8 mmole), and triethylamine (1.6 mL, 11 mmole) were dissolved in toluene (5 mL). The reaction was heated to 110°C for 48 hours and then cooled. Ether and water were added and the mixture was partitioned. The aqueous phase was extracted two times with ether and the combined organic phases were dried (MgSO4), concentrated, and chromatographed on silica gel with 50% ethyl acetate/hexane. The resultant viscous oil solidified after standing for several days (0.77 g, 44% yield). 1H NMR (CDCl3): δ 8.48 (s, 1H), 7.49, 7.32 (ABq, 4H), 6.04 (s, 1H), 5.25 (brd, 1H), 4.85 (m, 1H), 2.53 (q, 2H), 1.56 (d, 3H), 1.16 (t, 3H), 0.25 (s, 9H).
EXAMPLE 3
Step A: 6-ethyl-5-nitro-4-pyrimidinol
6-ethyl-4-pyrimidinol (1.0 g, 8.5 mmole) was dissolved in 10 mL of tetramethylene sulfone by warming to 30°C. Nitronium tetrafluoroborate (2.5 g, 19 mmole) was added portionwise and the reaction mixture was heated at 60°C for one hour. The reaction was cooled, poured into ice water, and extracted several times with ethyl acetate. The combined organic phases were washed two times with water, dried (MgSO4), concentrated, and chromatographed on silica gel with 10% methanol/ chloroform. The product was an orange solid (0.85 g, 59% yield). 1H NMR (CDCl3): δ 8.13 (s, 1H), 2.37 (q, 2H), 1.11 (t, 3H). IR (nujol, cm-1): 1581 (m), 1530 (m).
Step B: 4-chloro-6-ethyl-5-nitropyrimidine
The product of Step A (0.85 g, 5.0 mmole) was combined with phosphorus oxychloride (10 mL) and heated at 100°C for one hour, during which the slurry became homogeneous. The mixture was concentrated under vacuum and the residue was added to ice. Concentrated NH4OH solution was carefully added until the aqueous phase was basic. This solution was extracted several times with ether and the combined organic phases were dried (MgSO4) and concentrated to give a waxy solid product (0.64 g, 68% yield). 1H NMR (CDCl3): δ 9.00 (s, 1H), 2.84 (q, 2H), 1.39 (t, 3H) .
Step C: 6-ethyl-5-nitro-N-[1-[4-(trimethylsilyl)-phenyl]-ethyl]-4-pyrimidinamine
The product of Step B (0.80 g, 4.3 mmole),
α-methyl-4-trimethylsilylbenzenemethanamine (0.91 g, 4.7 mmole), and triethylamine (1.2 mL, 8.6 mmole) were dissolved in toluene (5 mL) and heated at 110°C for 3 hours. After cooling, the mixture was diluted with ether and water and partitioned. The aqueous phase was extracted several times with ether and the combined organic phases were dried (MgSO4), concentrated, and chromatographed on silica gel with 5% ethyl
acetate/hexane. The product was a yellow oil (1.3 g, 89% yield). 1H NMR (CDCl3): δ 8.51 (s, 1H), 8.02 (brd, 1H), 7.51, 7.35 (ABq, 4H), 5.51 (m, 1H), 2.97 (q, 2H), 1.62 (d, 3H), 1.32 (t, 3H), 0.25 (s, 9H).
By the procedures described herein, or obvious modifications thereof, the following compounds of
Tables 1 to 4 can be prepared. The compounds in Table 1, line 1 can be referred to as 1-1, 1-2, 1-3, 1-4 and 1-5 (as designated by line and column). All the other specific compounds covered in these Tables can be designated in an analogous fashion relying on the Table number to help distinguish between compounds 1-1 of Table 1 and 1-1 of Table 2, etc.
Figure imgf000020_0001
Figure imgf000021_0001
Figure imgf000022_0001
Figure imgf000023_0001
Figure imgf000024_0001
Figure imgf000025_0001
Figure imgf000026_0001
Figure imgf000027_0001
Figure imgf000028_0001
Figure imgf000029_0001
Figure imgf000030_0001
Figure imgf000031_0001
Figure imgf000032_0001
Figure imgf000033_0001
Figure imgf000034_0001
Figure imgf000034_0002
Figure imgf000035_0001
Figure imgf000036_0001
Figure imgf000037_0001
Figure imgf000038_0001
Figure imgf000039_0001
Figure imgf000040_0001
Figure imgf000041_0001
Figure imgf000042_0001
Figure imgf000043_0001
Figure imgf000044_0001
Figure imgf000045_0001
Figure imgf000046_0001
Figure imgf000047_0001
Figure imgf000048_0001
Figure imgf000049_0001
Figure imgf000050_0001
Formulation/Utility
Compounds of this invention will generally be used in formulation with an agriculturally suitable carrier comprising a liquid or solid diluent or an organic solvent. Useful formulations can be prepared in conventional ways. They include dusts, granules, baits, pellets, solutions, suspensions, emulsions, wettable powders, emulsifiable concentrates, dry flowables and the like. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High strength compositions are primarily used as intermediates for further formulation. The
formulations will typically contain effective amounts of an active ingredient, diluent and a surfactant within the following approximate ranges wherein the active ingredient plus surfactant and/or diluent equals 100 weight percent.
Weight Percent
Active
Ingredient Diluent Surfactant
Wettable Powders 25-90 0-74 1-10
Oil Suspensions, 5-50 40-95 0-15
Emulsions, Solutions,
(Including Emulsifiable
Concentrates)
Dusts 1-25 70-99 0-5
Granules, Baits and 0.01-99 5-99.99 0-15
Pellets
High Strength 90-99 0-10 0-2
Compositions Typical solid diluents are described in Watkins, et al., Handbook of Insecticide Dust Diluents and
Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. The more absorptive diluents are preferred for wettable powders and the denser ones for dusts. Typical liquid diluents and solvents are described in Marsden,
Solvents Guide, 2nd Ed., Interscience, New York, 1950. Solubility under 0.1% is preferred for suspension concentrates; solution concentrates are preferably stable against phase separation at 0°C. McCutcheon 's Detergents and Emulsifiers Annual, Allured Publ. Corp., Ridgewood, New Jersey, as well as Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, list surfactants and
recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth, etc. Preferably, ingredients should be approved by the U.S. Environmental Protection Agency for the use intended.
Methods for formulating such compositions are well known. Solutions are prepared by simply mixing the ingredients. Fine solid compositions are made by blending and, usually, grinding as in a hammer mill or fluid energy mill. Water-dispersible granules can be produced be agglomerating a fine powder composition; see for example, Cross et al., Pesticide Formulations, Washington, D.C., 1988, pp. 251-259. Suspensions are prepared by wet-milling; see, for example, U.S.
3,060,084. Granules and pellets can be made by
spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, "Agglomeration", Chemical Engineering, December 4, 1967, pages 147 and following, Perry's Chemical
Engineer 's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8 to 57 and following, and WO 91/13546.
Pellets can be prepared as described in U.S. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in DE 3,246,493.
For further information regarding the art of formulation, see U.S. Patent 3,235,361, Col. 6, line 16 through Col. 7, line 19 and Examples 10 through 41; U.S. Patent 3,309,192, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; U.S.
Patent 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a
Science, John Wiley and Sons, Inc., New York, 1961, pp. 81-96; and Hance et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989.
In the following Examples, all parts are by weight percent. Compound numbers refer to Index Table A.
Example A
High Strength Concentrate
Compound 1 98.5% silica aerogel 0.5% synthetic amorphous fine silica 1.0%
The ingredients are blended and ground in a hammer mill to produce a high strength concentrate,
essentially all particles passing a U.S.S. No. 50 sieve
(0.3.mm openings).
Example B
Wettable Powder
Compound 1 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium ligninsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0%
The ingredients are thoroughly blended. The liquid surfactant is added by spraying upon the solid
ingredients in the blender. After grinding in a hammer mill to produce particles essentially all below 100 microns, the material is reblended and sifted through a U.S.S. No. 50 sieve (0.3 mm opening).
Example C
Granule
Compound 1 10.0% attapulgite granules (low volative matter, 0.71/0.30 mm; U.S.S. No.
25-50 sieves) 90.0%
The active ingredient is dissolved in a volatile solvent such as acetone and sprayed upon dedusted and pre-warmed attapulgite granules in a double cone blender. The acetone is then driven off by heating , and the granules are allowed to cool.
Example D
Aqueous Suspension
Compound 1 25.0% hydrated attapulgite 3.0% crude calcium ligninsulfonate 10.0% sodium dihydrogen phosphate 0.5% water 61.5% The ingredients are ground together in a ball mill or roller mill until the solid particles have been reduced to diameters under 10 microns.
Example E
Extruded Pellet
Compound 1 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate 5.0% sodium alkylnaphthalenesulfonate 1.0% calcium/magnesium bentonite 59.0% The ingredients are blended, hammer-milled and then moistened with about 12% water. The mixture is extruded as cylinders about 3 mm diameter which are cut to produce pellets about 3 mm long. These can be used directly after drying, or the dried pellets can be crushed to pass a U.S.S. No. 20 sieve (0.84 mm
openings). The granules held on a U.S.S. No. 40 sieve (0.42 mm openings) can be used and the fines recycled.
Example F
Emulsifiable Concentrate
Compound 1 20.0% blend of oil soluble sulfonates and polyoxyethylene ethers 10.0% isophorone 70.0%
The ingredients are combined and stirred with gentle warming to speed solution. A fine screen filter is included in packaging operation to insure the absence of extraneous undissolved material in the product.
Example G
Dust
Wettable powder of Example B 10.0% pyrophyllite (powder) 90.0%
The wettable powder and the pyrophyllite diluent are thoroughly blended.
The compounds of this invention exhibit activity against a wide spectrum of foliar-feeding, fruit-feeding, seed-feeding, aquatic and soil-inhabiting arthropods (term includes insects, mites and nematodes) which are pests of growing and stored agronomic crops, forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health. Those skilled in the art will appreciate that not all compounds are equally effective against all pests. Nevertheless, all of the compounds of this invention display activity against pests that include: eggs, larvae and adults of the
Order Lepidoptera; eggs, foliar-feeding, fruit-feeding, root-feeding, seed-feeding larvae and adults of the Order Coleoptera; eggs, immatures and adults of the Orders Hemiptera and Homoptera; eggs, larvae, nymphs and adults of the Order Acari; eggs, immatures and adults of the Orders Thysanoptera, Orthoptera and
Dermaptera; eggs, immatures and adults of the Order Diptera; and eggs, juveniles and adults of the Phylum Nematoda. The compounds of this invention are also active against pests of the Orders Hymenoptera,
Isoptera, Phthiraptera, Siphonaptera, Blattaria, Thysanura and Pscoptera; pests belonging to the Class of Arachnida and Phylum Platyhelminthes. See
WO 90/10623 and WO 92/00673 for more detailed pest descriptions.
The compounds of this invention are also useful as plant disease control agents. They provide control of diseases caused by a broad spectrum of fungal plant pathogens in the Basidiomycete, Ascomycete and Oomycete classes. They are effective in controlling a broad spectrum of plant diseases, particularly foliar
pathogens of ornamental, vegetable, field, cereal, and fruit crops. These pathogens include Plasmopara viticola, Phytophthora infestans, Peronospora tabacina, Pseudoperonospora cubensis, Pythium aphanidermatum, Alternaria brassicae, Septoria nodorum, Cercosporidium personatum, Cercospora arachidicola, Pseudocercosporella herpotrichoides, Rhizoctinia Solani, Cercospora beticola, Botrytis cinerea, Monilinia fructicola, Pyricularia oryzae, Podosphaera
leucotricha, Venturia inaequalis, Erisyphe graminis, Puccinia recondita, Puccinia graminis, Hemileia
vastatrix, Puccinia striiformis, Puccinia arachidis, and other species closely related to these pathogens. The compounds of this invention also control seed pathogens.
Compounds of this invention can also be mixed with one or more other insecticides, fungicides,
nematocides, bactericides, acaricides, semiochemicals, repellants, attractants, pheromones, feeding stimulants or other biologically active compounds to form a multi-component pesticide giving an even broader spectrum of agricultural protection. Examples of other
agricultural protectants with which compounds of this invention can be formulated are: insecticides such as monocrotophos, carbofuran, avermectin B, tetrachlor-vinphos, malathion, parathion-methyl, methomyl, chlor- dimeform, diazinon, deltamethrin, oxamyl, fenvalerate, esfenvalerate, permethrin, profenofos, sulprofos, triflumuron, diflubenzuron, methoprene, buprofezin, thiodicarb, acephate, azinphosmethyl, chlorpyrifos, dimethoate, fonophos, isofenphos, methidathion, metha-midophos, phosmet, phosphamidon, phosalone, pirimicarb, phorate, terbufos, trichlorfon, methoxychlor,
bifenthrin, biphenate, cyfluthrin, fenpropathrin, fluvalinate, flucythrinate, tralomethrin, metaldehyde and rotenone; fungicides such as carbendazim, thiuram, dodine, maneb, chloroneb, benomyl, cymoxanil,
fenpropidine, fenpropimorph, triadimefon, captan, thiophanate-methyl, thiabendazole, phosethyl-Al, chlorothalonil, dichloran, metalaxyl, captafol,
iprodione, oxadixyl, vinclozolin, kasugamycin,
myclobutanil, tebuconazole, difenoconazole,
diniconazole, fluquinconazole, penconazole,
propiconazole, uniconzole, flutriafol, prochloraz, pyrifenox, fenarimol, triadimenol, diclobutrazol, copper oxychloride, furalaxyl, folpet and flusilazol; nematocides such as aldoxycarb, fenamiphos and
fosthietan; bactericides such as oxytetracyline, streptomycin and tribasic copper sulfate; acaricides such as binapacryl, oxythioquinox, chlorobenzilate, dicofol, dienochlor, cyhexatin, hexythiazox, amitraz, propargite and fenbutatin oxide; and biological agents such as Bacillus thuringiensis, and baculovirus.
In certain instances, combinations with other arthropodicides/fungicides having a similiar spectrum of control but a different mode of action will be particularly advantageous for resistance management.
Arthropod pests are controlled and protection of agronomic crops, animal and human health is achieved by applying one or more of the compounds of this
invention, in an effective amount, to the environment of the pests including the agronomic and/or non agronomic locus of infestation, to the area to be protected, or directly on the pests to be controlled. A preferred method of application is by spraying with equipment that distributes the compound in the
environment of the pests, on the foliage, animal, person, or premise, in the soil or animal, to the plant part that is infested or needs to be protected.
Alternatively, granular formulations of these compounds can be applied to the foliage or applied to or
incorporated into the soil. Other methods of
application can also be employed including direct and residual sprays, aerial sprays, systemic uptake, baits, eartags, boluses, foggers, fumigants, aerosols, and many others. The compounds can be incorporated into baits that are consumed by the arthropods or in devices such as traps and the like which entice them to ingest or otherwise contact the compounds.
Plant disease control is ordinarily accomplished by applying an effective amount of a compound of this invention either pre- or post-infection, to the portion of the plant to be protected such as the roots, stems, foliage, fruit, seeds, tubers or bulbs, or to the media (soil or sand) in which the plants to be protected are growing. The compounds can also be applied to the seed to protect the seed and seedling.
The compounds of this invention can be applied in their pure state, but most often application will be of a formulation comprising one or more compounds with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use. A preferred method of
application involves spraying a water dispersion or refined oil solution of the compounds. Combinations with spray oils, spray oil concentrations, spreader stickers, adjuvants, and synergists and other solvents such as piperonyl butoxide often enhance compound efficacy.
The rate of application required for effective control arthropod will depend on such factors as the species of arthropod to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like. In general, application rates of about 0.01 to 2 kg of active ingredient per hectare are sufficient to provide large-scale effective control of pests in agronomic ecosystems under normal circumstances, but as little as 0.001 kg/hectare may be sufficient or as much as 8 kg hectare may be required. For nonagronomic
applications, effective use rates will range from about 1.0 to 50 mg/square meter but as little as
0.1 mg/square meter may be sufficient or as much as 150 mg/square meter may be required.
Rates of application for these compounds as plant disease control agents can be influenced by many factors of the environment and should be determined under actual use conditions. Foliage can normally be protected when treated at a rate of from less than 1 g/ha to 10,000 g/ha of active ingredient. Seed and seedlings can normally be protected when seed is treated at a rate of from 0.1 to 10 g per kilogram of seed.
The following tests demonstrate the control
efficacy of compounds of Formula I on specific pests and plant pathogens; see index Tables A and B for compound descriptions. The pest control protection afforded by the compounds of the present invention is not limited, however, to these species. Compounds not included were either not screened or gave pathogen control levels less than 70% or insect control less than 80%.
Figure imgf000060_0001
Figure imgf000061_0001
TEST A
The test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem® 014 (polyhydric alcohol esters). This suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore dust of Erysiphe graminis f. sp . tritici (the causal agent of wheat powdery mildew) and incubated growth chamber at 20°C for 7 days, after which disease ratings were made. Of the compounds tested, the following gave 70% disease control or higher: 1, 2, 3, 4, 5, 7, 8, 9, 10, 12, 13, 14, 15, 16, 17, 18.
TEST B
The test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then
suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem® 014 (polyhydric alcohol esters. This suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore suspension of Puccinia recondita (the causal agent of wheat leaf rust) and incubated in a saturated atmosphere at 20°C for 24 hours, and then moved to a growth chamber at 20°C for 6 days, after which disease ratings were made. Of the compounds tested, the following gave 70% disease control or higher: 1, 2, 3, 4, 5, 7, 8 , 9, 10, 13, 14, 15, 16, 17, 18.
TEST C
The test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then
suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem® 014 (polyhydric alcohol esters). This suspension was sprayed to the point of run-off on grape seedlings. The following day the seedlings were inoculated with a spore suspension of Plasmopara viticola (the causal agent of grape downey mildew) and incubated in a saturated atmosphere at 20°C for 6 days, and then incubated in a saturated atmosphere at 20°C for 24 hours, after which disease ratings were made. Of the compounds tested, the following gave 70% disease control or higher when tested at 40 ppm: 1, 2, 3, 5, 8, 9, 10, 12, 13, 14, 1.5, 16, 17, 18.
TEST D
The test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem® 014 (polyhydric alcohol esters). This suspension is sprayed to the point of run-off on rice seedlings. The following day the seedlings are inoculated with a spore suspension of Pyricularia oryzae (the causal agent of rice blast) and incubated in a saturated atmosphere at 27°C for 24 h, and then moved to a growth chamber at 30°C for 5 days, after which disease ratings are made. Of. the compounds tested, the following gave 70% disease control or higher: 1, 2, 7, 18.
TEST E
Two spotted Spider Mite
One ince squares (2.54 centimeters) of kidney bean leaves that have been infested on the undersides with 25 to 30 adult mites ( Tetranychus urticae) were sprayed with their undersides facing up on a hydraulic sprayer.
Solutions of each of the test compounds
(acetone/distilled water 75/25 solvent) were sprayed by passing the leaves on a conveyer belt, directly beneath a flat fan hydraulic nozzle which discharged the spray at a rate of 0.5 pounds of active ingredient per acre (about 0.55 kg/ha) at 30 psi (207 kPa).
The leaf-squares were placed underside up on a square of wet cotton in a petri dish and the perimeter of the leaf square was tamped down onto the cotton with forceps so that the mites cannot escape onto untreated leaf surface. The test units were held at 27°C and 50% relative humidity for 48 hrs., after which time
mortality readings were taken. Of the compounds tested, the following gave levels of 80% or higher: 2 , 5 , 1 , 8, 10, 12, 14, 16, 17, 18. TEST F
Two spotted Spider Mite (Tetranychus urticae)
Ovicide Test
Two week old red kidney bean plants infested with two spotted spider mite eggs were sprayed to run-off using a turntable sprayer. Rates of 50 and 20 ppm active ingredient were applied. Plants were held in a chamber at 25°C and 50% relative humidity. Seven days after spray, mortality readings were conducted for egg and larval mortality and are reported below.
% Mortality 7 Days
Compound Rate PPM AI Ovicide Larvicide
2 50 91 83
20 46 96

Claims

What is claimed is:
1. A compound of Formula I :
Figure imgf000065_0001
wherein
Q is
,
or
Figure imgf000065_0002
Figure imgf000065_0003
;
Figure imgf000065_0004
A is C2-C5 straight or branched chain alkylene or C3-C6 cycloalkylene, wherein any one atom of A can be optionally substituted with R7;
X is Ge or Si;
R1 is H, halogen, C1-C4 alkyl or C1-C4 haloalkyl;
R2 is H, halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C4 cyanoalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl;
R3 is H, halogen, CN, NO2, CO2R16, C(O)R16,
C(O)N(R16)R17, OR16, SR16, S(O)R16, S (O) 2R16, N(R16)R17, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C1-C6 hydroxyalkyl, C2-C6 alkoxyalkyl, C2-C6 haloalkoxyalkyl, C2-C6 cyanoalkyl, C2-C6 alkylthioalkyl, C2-C6 haloalkylthioalkyl, C3-C4 cycloalkyl, SCN or C1-C6 alkyl substituted with N(R16)R17; provided that (i) when R2 is H, halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl then R3 is other than halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl and (ii) when R3 is H, then R5 is other than C1-C6 haloalkylthio, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, C1-C6 alkylsulfonyl, C1-C6 alkylsulfinyl or C1-C6 alkylthio;
R4 is H, formyl, C2-C6 alkoxyalkyl C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6
haloalkoxycarbonyl, C(O)R15, R11OC(O)S-, R11OC(O)N(R12)S-, R11(R12)NS- or SR8; or R4 is C1-C6 alkyl optionally substituted with halogen, CN, NO2, S(O)nR11, C(O)R11, CO2R11 or
C1-C3 haloalkoxy; or R4 is phenyl optionally substituted with halogen, CN, and C1-C2 haloalkyl;
R5 is C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkoxyalkyl, C2-C6 alkoxyalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 alkenyloxy, C2-C6 alkynyloxy, C3-C6 cycloalkyl, C3-C6 cycloalkylalkyl, C1-C6 alkylthio, C2-C6 alkylthioalkyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylthio, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, phenyl optionally substituted with W or phenoxy optionally substituted with W;
R6 is H, halogen, CN, NO2, C1-C2 alkyl, C1-C2 alkoxy or CF3;
R7 is CN, C(O)R8, CO2R8, C(O)N(R8)R9, N3, NO2,
N(R8)R9, N(R8)C(O)R9, N(R8)C(O)N(R10)R9,
N(R8)S(O)2R10, OR8, OC(O)R8, OCO2R8,
OC(O)N(R8)R9, OS(O)2R8, SR8, S(O)R8, S(O)2R8, SCN or 1-3 halogens;
R8 and R10 are independently H, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C3-C6 haloalkynyl, C2-C6
alkoxyalkyl, C2-C6 alkylthioalkyl, C1-C6
nitroalkyl, C2-C6 cyanoalkyl, C3-C8
alkoxycarbonylalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, phenyl optionally substituted with W; or benzyl optionally substituted with W on the phenyl ring;
R9 is H or C1-C4 alkyl; or
R8 and R9 can be taken together when attached to the same atom as -(CH2)4-, -(CH2)5- or
-CH2CH2OCH2CH2-;
R11 and R12 are independently C1-C4 alkyl;
R13 is C1-C4 alkyl, C1-C4 alkoxyalkyl or phenyl
optionally substituted with W;
R14 is C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkoxy,
C1-C6 haloalkoxy, C1-C6 haloalkoxy, phenyl or benzyl, each phenyl or benzyl optionally substituted with W on the aryl ring;
R15 is
, , or ;
Figure imgf000067_0001
Figure imgf000067_0002
Figure imgf000067_0003
Figure imgf000067_0004
R16 and R17 are independently H, C1-C4 alkyl or C1-C4 haloalkyl;
W is CN, NO2, C1-C2 alkyl, C1-C2 haloalkyl, C1-C2 alkoxy, C1-C2 haloalkoxy, C1-C2 alkylthio, C1-C2 haloalkylthio, C1-C2 alkylsulfonyl, C1-C2 haloalkylsulfonyl or 1-5 halogens; and
n is 0, 1 or 2.
2. A compound of Claim 1 wherein:
A is C1-C5 straight or branched alkylene;
R1 is H;
R2 is C1-C6 alkyl, C2-C4 cyanoalkyl or C1-C4 haloalkyl;
R4 is H;
R5 is C1-C6 alkyl, C1-C6 haloalkoxy, C2-C6 alkoxyalkyl, C2-C6 alkoxyalkoxy or phenoxy optionally substituted with W; R6 is H, halogen or C1-C2 alkyl;
R11, R12 and R13 are independently C1-C2
alkyl;
R14 is C1-C4 alkyl, C1-C4 alkoxy or phenyl
optionally substituted with W; and
W is halogen or C1-C2 haloalkyl.
3. A compound of Claim 2 wherein Q is
Figure imgf000068_0001
4. A compound of Claim 2 wherein Q is
Figure imgf000069_0001
5. A compound of Claim 2 wherein Q is
Figure imgf000069_0002
6. A compound which is
6-ethyl-4-[[1-4[4-(trimethylsilyl)phenyl]ethyl]- amino]-5-pyrimidinecarbonitrile.
7. An arthropodicidal or fungicidal composition comprising an effective amount of a compound of
Formula I
Figure imgf000069_0003
wherein
Q is ,
or
Figure imgf000070_0001
Figure imgf000070_0002
;
Figure imgf000070_0003
A is C1-C5 straight or branched chain alkylene or
C3-C6 cycloalkylene, wherein any one atom of A can be optionally substituted with R7; X is Ge or Si;
R1 is H, halogen, C1-C4 alkyl or C1-C4 haloalkyl; R2 is H, halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C4 cyanoalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl;
R3 is H, halogen, CN, NO2, CO2R16, C (O) R16,
C (O) N (R16) R17, OR16, SR16, S (O) R16, S (O) 2R16, N (R16) R17, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C1-C6 hydroxyalkyl, C2-C6 alkoxyalkyl, C2-C6 haloalkoxyalkyl, C2-C6 cyanoalkyl, C2-C6 alkylthioalkyl, C2-C6 haloalky Ithioalkyl, C3-C4 cycloalkyl, SCN or C1-C6 alkyl substituted with N (R16) R17;
provided that (i) when R2 is H, halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl then R3 is other than halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl and (ii) when R3 is H, then R5 is other than C1-C6 haloalkylthio, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, C1-C6 alkylsulfonyl,. C1-C6 alkylsulfinyl or C1-C6 alkylthio;
R4 is H, formyl, C2-C6 alkoxyalkyl C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 haloalkoxycarbonyl, C(O)R15, R11OC(O)S-,
R11OC(O)N(R12)S-, R11(R12)NS- or SR8; or R4 is C1-C6 alkyl optionally substituted with halogen, CN, NO2, S(O)nR11, C(O)R11, CO2R11 or
C1-C3 haloalkoxy; or R4 is phenyl optionally substituted with halogen, CN, and C1-C2 haloalkyl;
R5 is C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkoxyalkyl, C2-C6 alkoxyalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 alkenyloxy, C2-C6 alkynyloxy, C3-C6 cycloalkyl, C3-C6 cycloalkylalkyl, C1-C6 alkylthio, C1-C6 alkylthioalkyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylthio, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, phenyl optionally substituted with W or phenoxy optionally substituted with W;
R6 is H, halogen, CN, NO2, C1-C2 alkyl, C1-C2 alkoxy or CF3;
R7 is CN, C(O)R8, CO2R8, C(O)N(R8)R9, N3, NO2,
N(R8)R9, N(R8)C(O)R9, N (R8) C (O) N (R10) R9, N(R8)S(O)2R10, OR8, OC(O)R8, OCO2R8,
OC(O)N(R8)R9, OS(O)2R8, SR8, S(O)R8, S(O)2R8, SCN or 1-3 halogens;
R8 and R10 are independently H, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C3-C6 haloalkynyl, C2-C6 alkoxyalkyl, C2-C6 alkylthioalkyl, C1-C6 nitroalkyl, C2-C6 cyanoalkyl, C3-C8 alkoxycarbonylalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, phenyl optionally substituted with W; or benzyl optionally substituted with W on the phenyl ring;
R9 is H or C1-C4 alkyl; or
R8 and R9 can be taken together when attached to the same atom as -(CH2)4-, -(CH2)5- or
-CH2CH2OCH2CH2-;
R11 and R12 are independently C1-C4 alkyl;
R13 is C1-C4 alkyl, C1-C4 alkoxyalkyl or phenyl
optionally substituted with W;
R14 is C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkoxy,
C1-C6 haloalkoxy, C1-C6 haloalkoxy, phenyl or benzyl, each phenyl or benzyl optionally substituted with W on the aryl ring;
R15 is
, , or ;
Figure imgf000072_0001
Figure imgf000072_0002
Figure imgf000072_0003
Figure imgf000072_0004
R16 and R17 are independently H, C1-C4 alkyl or
C1-C4 haloalkyl;
W is CN, NO2, C1-C2 alkyl, C1-C2 haloalkyl, C1-C2 alkoxy, C1-C2 haloalkoxy, C1-C2 alkylthio, C1-C2 haloalkylthio, C1-C2 alkylsulfonyl, C1-C2 haloalkylsulfonyl or 1-5 halogens; and
n is 0, 1 or 2.
and at least one of (a) a surfactant, (b) an organic solvent, and (c) at least one solid or liquid diluent.
8. A method for controlling plant pathogens or foliar, aquatic, and soil-inhabiting anthropod pests comprising applying to the locus of infestation, area to be protected or directly onto said pests, an
effective amount of a compound of Formula I
Figure imgf000073_0001
wherein
Q is
or ,
Figure imgf000073_0002
Figure imgf000073_0003
;
Figure imgf000073_0004
A is C1-C5 straight or branched chain alkylene or
C3-C6 cycloalkylene, wherein any one atom of A can be optionally substituted with R7; X is Ge or Si;
R1 is H, halogen, C1-C4 alkyl or C1-C4 haloalkyl; R2 is H, halogen, C1-C6 alkyl, C1-C6 haloalkyl,
C2-C4 cyanoalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl;
R3 is H, halogen, CN, NO2, CO2R16, C(O)R16,
C(O)N(R16)R17, OR16, SR16, S(O)R16, S(O)2R16,
N(R16)R17, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C1-C6 hydroxyalkyl, C2-C6 alkoxyalkyl, C2-C6 haloalkoxyalkyl, C2-C6 cyanoalkyl, C2-C6 alkylthioalkyl, C2-C6 haloalkylthioalkyl, C3-C4 cycloalkyl, SCN or
C1-C6 alkyl substituted with N(R16)R17; provided that (i) when R2 is H, halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl then R3 is other than halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkoxyalkyl or C2-C6 alkylthioalkyl and (ii) when R3 is H, then R5 is other than C1-C6 haloalkylthio, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, C1-C6 alkylsulfonyl, C1-C6 alkylsulfinyl or C1-C6 alkylthio;
R4 is H, formyl, C2-C6 alkoxyalkyl C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6
haloalkoxycarbonyl, C(O)R15, R11OC(O)S-, R11OC(O)N(R12)S-, R11(R12)NS- or SR8; or R4 is C1-C6 alkyl optionally substituted with halogen, CN, NO2, S(O)nR11, C(O)R11, CO2R11 or
C1-C3 haloalkoxy; or R4 is phenyl optionally substituted with halogen, CN, and C1-C2 haloalkyl;
R5 is C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkoxyalkyl, C2-C6 alkoxyalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 alkenyloxy, C2-C6 alkynyloxy, C3-C6 cycloalkyl, C3-C6 cycloalkylalkyl, C1-C6 alkylthio, C2-C6 alkylthioalkyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylthio, C1-C6 haloalkylsulfinyl, C1-C6 haloalkylsulfonyl, phenyl optionally substituted with W or phenoxy optionally substituted with W;
R6 is H, halogen, CN, NO2, C1-C2 alkyl, C1-C2 alkoxy or CF3; R7 is CN, C(O)R8, C02R8, C(O)N(R8)R9, N3, NO2,
N(R8)R9, N(R8)C(O)R9, N (R8) C (O) N (R10) R9,
N(R8)S(O)2R10, OR8, OC(O)R8, OCO2R8,
OC(O)N(R8)R9, OS(O)2R8, SR8, S(O)R8, S(O)2R8, SCN or 1-3 halogens;
R8 and R10 are independently H, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C3-C6 haloalkynyl, C2-C6
alkoxyalkyl, C2-C6 alkylthioalkyl, C1-C6
nitroalkyl, C2-C6 cyanoalkyl, C3-C8
alkoxycarbonylalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, phenyl optionally substituted with W; or benzyl optionally substituted with W on the phenyl ring;
R9 is H or C1-C4 alkyl;
R8 and R9 can be taken together when attached to the same atom as -(CH2)4-, -(CH2)5- or
-CH2CH2OCH2CH2-;
R11 and R12 are independently C1-C4 alkyl;
R13 is C1-C4 alkyl, C1-C4 alkoxyalkyl or phenyl
optionally substituted with W;
R14 is C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkoxy,
C1-C6 haloalkoxy, C1-C6 haloalkoxy, phenyl or benzyl, each phenyl or benzyl optionally substituted with W on the aryl ring;
R15 is , , or ;
Figure imgf000075_0001
Figure imgf000075_0002
Figure imgf000075_0003
Figure imgf000075_0004
R16 and R17 are independently H, C1-C4 alkyl or
C1-C4 haloalkyl;
W is CN, NO2, C1-C2 alkyl, C1-C2 haloalkyl, C1-C2 alkoxy, C1-C2 haloalkoxy, C1-C2 alkylthio, C1-C2 haloalkylthio, C1-C2 alkylsulfonyl, C1-C2 haloalkylsulfonyl or 1-5 halogens; and n is 0, 1 or 2.
9. A method for controlling plant pathogens or foliar, aquatic, and soil-inhabiting anthropod pests comprising applying to the locus of infestation, area to be protected, or directly onto said pests an effective amount of a composition of Claim 7.
PCT/US1993/002757 1992-04-24 1993-03-22 Arthropodicidal and fungicidal aminopyrimidines WO1993022291A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87346992A 1992-04-24 1992-04-24
US07/873,469 1992-04-24
US93614592A 1992-08-26 1992-08-26
US07/936,145 1992-08-26

Publications (1)

Publication Number Publication Date
WO1993022291A1 true WO1993022291A1 (en) 1993-11-11

Family

ID=27128300

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/002757 WO1993022291A1 (en) 1992-04-24 1993-03-22 Arthropodicidal and fungicidal aminopyrimidines

Country Status (2)

Country Link
AU (1) AU3933493A (en)
WO (1) WO1993022291A1 (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0665225A1 (en) * 1994-02-01 1995-08-02 Ube Industries, Ltd. 4-Phenethylamino pyrimidine derivative, process for preparing the same and agricultural and horticultural chemical for controlling noxious organisms containing the same
US5439911A (en) * 1992-12-28 1995-08-08 Shionogi & Co., Ltd. Aminopyrimidine derivatives and their production and use
WO1998007421A1 (en) * 1996-08-16 1998-02-26 Ishihara Sangyo Kaisha, Ltd. Medicinal composition
US5852023A (en) * 1995-03-29 1998-12-22 Hoechst Schering Agrevo Gmbh Cyclohexylamino and cycloalkoxy nitrogen heterocycles, processes for their preparation, and their use as pesticides and fungicides
WO2012096061A1 (en) * 2011-01-14 2012-07-19 株式会社エス・ディー・エス バイオテック Pyrimidine-derived pest-control agent for use in agriculture and horticulture
US20140057912A1 (en) * 2011-03-25 2014-02-27 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
CN104292169A (en) * 2013-07-19 2015-01-21 中国中化股份有限公司 Substituted pyrimidinamine compound and use thereof
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
US9193721B2 (en) 2010-04-14 2015-11-24 Incyte Holdings Corporation Fused derivatives as PI3Kδ inhibitors
US9199982B2 (en) 2011-09-02 2015-12-01 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US9296701B2 (en) 2012-04-24 2016-03-29 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US9309251B2 (en) 2012-04-02 2016-04-12 Incyte Holdings Corporation Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
US9340557B2 (en) 2013-03-12 2016-05-17 Vertex Pharmaceuticals Incorporated Substituted quinoxaline DNA-PK inhibitors
US9403847B2 (en) 2009-12-18 2016-08-02 Incyte Holdings Corporation Substituted heteroaryl fused derivatives as P13K inhibitors
US9434746B2 (en) 2009-06-29 2016-09-06 Incyte Corporation Pyrimidinones as PI3K inhibitors
US9527848B2 (en) 2010-12-20 2016-12-27 Incyte Holdings Corporation N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
US10039761B2 (en) 2013-10-17 2018-08-07 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
US10336759B2 (en) 2015-02-27 2019-07-02 Incyte Corporation Salts and processes of preparing a PI3K inhibitor
US11110108B2 (en) 2016-09-27 2021-09-07 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
US11980633B2 (en) 2021-07-29 2024-05-14 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0264217A2 (en) * 1986-10-08 1988-04-20 Ube Industries, Ltd. Aralkylaminopyrimidine derivative, process for producing thereof and insecticide, acaricide and fungicide containing said derivative as active ingredient
EP0370704A2 (en) * 1988-11-21 1990-05-30 Ube Industries, Ltd. Aralkylamine derivatives, preparation thereof and fungicides containing the same
EP0424125A2 (en) * 1989-10-18 1991-04-24 Ube Industries, Ltd. Aralkylamine derivatives, preparation method thereof and fungicides containing the same
EP0519211A1 (en) * 1991-05-17 1992-12-23 Hoechst Schering AgrEvo GmbH Substituted 4-aminopyrimidine, process for their preparation and their use as parasiticide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0264217A2 (en) * 1986-10-08 1988-04-20 Ube Industries, Ltd. Aralkylaminopyrimidine derivative, process for producing thereof and insecticide, acaricide and fungicide containing said derivative as active ingredient
EP0370704A2 (en) * 1988-11-21 1990-05-30 Ube Industries, Ltd. Aralkylamine derivatives, preparation thereof and fungicides containing the same
EP0424125A2 (en) * 1989-10-18 1991-04-24 Ube Industries, Ltd. Aralkylamine derivatives, preparation method thereof and fungicides containing the same
EP0519211A1 (en) * 1991-05-17 1992-12-23 Hoechst Schering AgrEvo GmbH Substituted 4-aminopyrimidine, process for their preparation and their use as parasiticide

Cited By (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439911A (en) * 1992-12-28 1995-08-08 Shionogi & Co., Ltd. Aminopyrimidine derivatives and their production and use
US5519139A (en) * 1992-12-28 1996-05-21 Shionogi & Co., Ltd. Aminopyrimidine derivatives and their production and use
EP0665225A1 (en) * 1994-02-01 1995-08-02 Ube Industries, Ltd. 4-Phenethylamino pyrimidine derivative, process for preparing the same and agricultural and horticultural chemical for controlling noxious organisms containing the same
US5852023A (en) * 1995-03-29 1998-12-22 Hoechst Schering Agrevo Gmbh Cyclohexylamino and cycloalkoxy nitrogen heterocycles, processes for their preparation, and their use as pesticides and fungicides
WO1998007421A1 (en) * 1996-08-16 1998-02-26 Ishihara Sangyo Kaisha, Ltd. Medicinal composition
US6429212B1 (en) * 1996-08-16 2002-08-06 Ishihara Sangyo Kaisha Ltd. Medicinal composition
US6515129B1 (en) 1996-08-16 2003-02-04 Ishihara Sangyo Kaisha Ltd. Pharmaceutical composition
US9975907B2 (en) 2009-06-29 2018-05-22 Incyte Holdings Corporation Pyrimidinones as PI3K inhibitors
US11401280B2 (en) 2009-06-29 2022-08-02 Incyte Holdings Corporation Pyrimidinones as PI3K inhibitors
US9434746B2 (en) 2009-06-29 2016-09-06 Incyte Corporation Pyrimidinones as PI3K inhibitors
US10428087B2 (en) 2009-06-29 2019-10-01 Incyte Corporation Pyrimidinones as PI3K inhibitors
US10829502B2 (en) 2009-06-29 2020-11-10 Incyte Corporation Pyrimidinones as PI3K inhibitors
US9403847B2 (en) 2009-12-18 2016-08-02 Incyte Holdings Corporation Substituted heteroaryl fused derivatives as P13K inhibitors
US9193721B2 (en) 2010-04-14 2015-11-24 Incyte Holdings Corporation Fused derivatives as PI3Kδ inhibitors
US9815839B2 (en) 2010-12-20 2017-11-14 Incyte Corporation N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
US9527848B2 (en) 2010-12-20 2016-12-27 Incyte Holdings Corporation N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
WO2012096061A1 (en) * 2011-01-14 2012-07-19 株式会社エス・ディー・エス バイオテック Pyrimidine-derived pest-control agent for use in agriculture and horticulture
JP2012148981A (en) * 2011-01-14 2012-08-09 Sds Biotech Corp Pyrimidine derivative as pest controlling agent for agriculture and horticulture
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
US9126948B2 (en) * 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
US20140057912A1 (en) * 2011-03-25 2014-02-27 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
US11433071B2 (en) 2011-09-02 2022-09-06 Incyte Corporation Heterocyclylamines as PI3K inhibitors
US10646492B2 (en) 2011-09-02 2020-05-12 Incyte Corporation Heterocyclylamines as PI3K inhibitors
US9199982B2 (en) 2011-09-02 2015-12-01 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US11819505B2 (en) 2011-09-02 2023-11-21 Incyte Corporation Heterocyclylamines as PI3K inhibitors
US10376513B2 (en) 2011-09-02 2019-08-13 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US9707233B2 (en) 2011-09-02 2017-07-18 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US9730939B2 (en) 2011-09-02 2017-08-15 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US10092570B2 (en) 2011-09-02 2018-10-09 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US9944646B2 (en) 2012-04-02 2018-04-17 Incyte Holdings Corporation Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
US9309251B2 (en) 2012-04-02 2016-04-12 Incyte Holdings Corporation Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
US10259818B2 (en) 2012-04-02 2019-04-16 Incyte Corporation Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
US9925188B2 (en) 2012-04-24 2018-03-27 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors and uses thereof
US10391095B2 (en) 2012-04-24 2019-08-27 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US10442791B2 (en) 2012-04-24 2019-10-15 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US11008305B2 (en) 2012-04-24 2021-05-18 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US10076521B2 (en) 2012-04-24 2018-09-18 Vertex Pharamceuticals Incorporated DNA-PK inhibitors
US9296701B2 (en) 2012-04-24 2016-03-29 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US10501439B2 (en) 2012-04-24 2019-12-10 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US9878993B2 (en) 2012-04-24 2018-01-30 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors for treatment of cancer
US9376448B2 (en) 2012-04-24 2016-06-28 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US11021465B2 (en) 2012-04-24 2021-06-01 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US9592232B2 (en) 2012-04-24 2017-03-14 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US11813267B2 (en) 2013-03-12 2023-11-14 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US10258627B2 (en) 2013-03-12 2019-04-16 Vertex Pharmaceutical Incorporated DNA-PK inhibitors
US9987284B2 (en) 2013-03-12 2018-06-05 Vertex Pharmaceuticals Incorporated Substituted benzooxadiazole DNA-PK inhibitors
US9359380B2 (en) 2013-03-12 2016-06-07 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US10786512B2 (en) 2013-03-12 2020-09-29 Vertex Pharmaceuticals Incorporated DNA-PK inhibitors
US9340557B2 (en) 2013-03-12 2016-05-17 Vertex Pharmaceuticals Incorporated Substituted quinoxaline DNA-PK inhibitors
US10973830B2 (en) 2013-03-12 2021-04-13 Vertex Pharmaceuticals Incorporated Substituted quinoxaline DNA-PK inhibitors
CN104292169A (en) * 2013-07-19 2015-01-21 中国中化股份有限公司 Substituted pyrimidinamine compound and use thereof
US10039761B2 (en) 2013-10-17 2018-08-07 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
US10716789B2 (en) 2013-10-17 2020-07-21 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
US10479803B2 (en) 2014-06-11 2019-11-19 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
US11130767B2 (en) 2014-06-11 2021-09-28 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
US10336759B2 (en) 2015-02-27 2019-07-02 Incyte Corporation Salts and processes of preparing a PI3K inhibitor
US11084822B2 (en) 2015-02-27 2021-08-10 Incyte Corporation Salts and processes of preparing a PI3K inhibitor
US10125150B2 (en) 2015-05-11 2018-11-13 Incyte Corporation Crystalline forms of a PI3K inhibitor
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
US11110108B2 (en) 2016-09-27 2021-09-07 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
US11980633B2 (en) 2021-07-29 2024-05-14 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

Also Published As

Publication number Publication date
AU3933493A (en) 1993-11-29

Similar Documents

Publication Publication Date Title
WO1993022291A1 (en) Arthropodicidal and fungicidal aminopyrimidines
AU658159B2 (en) Insecticidal, acaricidal and fungicidal aminopyrimidines
WO1995007278A1 (en) Fungicidal, miticidal and arthropodicidal aminopyrimidines
JP3597194B2 (en) Arthropodic oxazolines and thiazolines
WO1995003306A1 (en) Arthropodicidal azacyclic heterocycles
WO1999031072A1 (en) Cyclohexylamine arthropodicides and fungicides
US5728693A (en) Arthropodicidal oxadiazine-thiadiazine-or triazine-carboxanilides
US5328915A (en) Arthropodicidal amidrazone ureas
EP0632803B1 (en) Arthropodicidal amides
EP0869963A1 (en) Arthropodicidal and fungicidal organosilanes and organogermanes
WO1997011057A1 (en) Arthropodicidal 1,4-dihydropyridines and 1,4-dihydropyrimidines
WO1995019972A1 (en) Arthropodicidal 2-oxa and thia-zolines
WO1994008976A1 (en) Fungicidal and miticidal aminopyrimidines
EP0636121A1 (en) Arthropodicidal pyrazole sulfonates
US5444079A (en) Arthropodicidal oxazolines
AU3058492A (en) Arthropodicidal and nematicidal sulfonates
EP0533734A1 (en) Fungicidal iminooxazolidinones
WO1995016676A1 (en) Arthropodicidal pentafluorothio substituted anilides
WO1993022289A1 (en) Arthropodicidal imidazolidines
US5514678A (en) Arthropodicidal 1,2,4-triazinyl amides
WO1993021150A2 (en) Arthropodicidal aryl sulfonates
WO1993021161A1 (en) Arthropodical nitroethylenes and nitroguanidines
WO1995000491A1 (en) Arthropodicidal sulfonates
EP0629201A1 (en) Arthropodicidal amides
WO1996033180A1 (en) Oxazoline and thiazoline arthropodicides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR JP NZ US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase